Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 10/20 | 0.58 |
| ▸ | GHSR | Q92847 | 3/20 | 0.50 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.50 |
| ▸ | NPY2R | P49146 | 2/20 | 0.49 |
| ▸ | GRPR | P30550 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19334855 | 1.00 | MC4R (0.58) | MC4RGHSRIL23RNPY2RGRPR | |
| SCHEMBL19334909 | 1.00 | MC4R (0.58) | MC4RGHSRIL23RNPY2RGRPR | |
| SCHEMBL20108376 | 0.92 | MC4R (0.57) | MC4RGHSRGRPR | |
| SCHEMBL23430098 | 0.92 | MC4R (0.59) | MC4RGHSR | |
| SCHEMBL14511692 | 0.90 | MC4R (0.71) | MC4RGHSRIL23RNPY2R | |
| SCHEMBL20108313 | 0.88 | IL23R (0.49) | MC4RIL23R | |
| SCHEMBL23430256 | 0.88 | IL23R (0.48) | MC4RIL23R | |
| SCHEMBL20108406 | 0.87 | MC4R (0.61) | MC4RGHSRIL23RNPY2RGRPR | |
| SCHEMBL14511696 | 0.87 | MC4R (0.67) | MC4RGHSRIL23RNPY2R | |
| SCHEMBL20108277 | 0.85 | MC4R (0.61) | MC4RGHSRIL23RGRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118784-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | IPSEN PHARMA S.A.S. (FR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118784-A1 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | MC4R, MC3R, MC1R | MC4R 1/4885GHSR 103/4885IL23R 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.